FIELD: biotechnology.
SUBSTANCE: specialized collection of vertebrata cell cultures of the Russian cell culture collection under the RCCC (P) registration number 727D. The cell line has stable cultural and morphological characteristics, is featured by the expression of differentiation tumor-associated antigens - MelanA, MITF, gp100, S100, tyrosinase, TRP-1; tumor-associated testis-specific antigens - NY-ESO-1 and MAGE, BAGE, GAGE, LAGE families.
EFFECT: invention allows you to test the activity of various pharmaceutical products, create diagnostic sets and test systems to develop new pharmaceuticals and new therapeutic approaches, in particular, allows you to create a model system to determine the optimum doses of photosensitizer for photodynamic therapy, as well as to prepare antitumor vaccine based on activated dendritic cells.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF HUMAN SKIN MELANOMA CELL LINE 388mel | 2018 |
|
RU2675541C1 |
| HUMAN COLORECTAL CANCER CELL LINE 485 COLO CAN | 2017 |
|
RU2650757C1 |
| APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
| CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| HUMAN MELANOMA CELLULAR LINE mel Kor USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287578C1 |
| HUMAN MELANOMA CELLULAR LINE mel P USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287575C1 |
| HUMAN MELANOMA CELL LINE mel Ch, USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2373279C1 |
| HUMAN MELANOMA CELL LINE mel Bgf USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2390557C1 |
| HUMAN MELANOMA CELLULAR LINE mel Ibr USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287576C1 |
